Transcript 12-Amino-acids - WatCut

Metabolic uses of amino acids
●
building blocks for protein synthesis
●
precursors of nucleotides and heme
●
source of energy
●
neurotransmitters
●
precursors of neurotransmitters and hormones
Outline of amino acid degradation
●
The liver is the major site of degradation for most amino
acids, but muscle and kidney dominate the degradation of
specific ones
●
Nitrogen is removed from the carbon skeleton and transferred
to α-ketoglutarate, which yields glutamate
●
The carbon skeletons are converted to intermediates of the
mainstream carbon oxidation pathways via specific adapter
pathways
●
Surplus nitrogen is removed from glutamate, incorporated
into urea, and excreted
Amino acid breakdown pathways join mainstream
carbon utilization at different points of entry
© Michael Palmer 2014
Transamination of amino acids
© Michael Palmer 2014
The reaction mechanism of transamination
© Michael Palmer 2014
The ping pong bi bi mechanism of transamination
© Michael Palmer 2014
Nitrogen disposal and excretion
●
Nitrogen accruing outside the liver is transported to the liver
as glutamine or alanine
●
In the liver, nitrogen is released as free ammonia
●
Ammonia is incorporated into urea
●
Urea is released from the liver into the bloodstream and
excreted through the kidneys
The urea cycle, part 1: carbamoylphosphate
synthetase
© Michael Palmer 2014
The urea cycle, part 2: subsequent reactions
© Michael Palmer 2014
The urea cycle in context
© Michael Palmer 2014
The urea cycle spans mitochondria and cytosol
© Michael Palmer 2014
The glucose-alanine cycle
© Michael Palmer 2014
Nitrogen transport by glutamine
© Michael Palmer 2014
The central role of glutamate in nitrogen disposal
© Michael Palmer 2014
Control of ammonia levels in the liver lobule
© Michael Palmer 2014
Regulation of the urea cycle
© Michael Palmer 2014
Hereditary enzyme defects in the urea cycle
●
may affect any of the enzymes in the cycle
●
urea cannot be synthesized, nitrogen disposal is disrupted
●
ammonia accumulates, as do other metabolites depending on
the deficient enzyme
●
treatment
○
protein-limited diet
○
arginine substitution
○
alternate pathway therapy
Asparagine degradation
© Michael Palmer 2014
Serine dehydratase
© Michael Palmer 2014
Serine-pyruvate transaminase
© Michael Palmer 2014
Degradation of leucine
© Michael Palmer 2014
Degradation of phenylalanine and tyrosine
© Michael Palmer 2014
Phenylketonuria (PKU)
●
homozygous defect of phenylalanine hydroxylase
●
affects one in 10,000 newborns among Caucasians; frequency
differs with race
●
excess of phenylalanine causes symptoms only after birth;
intrauterine development normal
●
cognitive and neurological deficits, probably due to cerebral
serotonin deficit
●
treatment with phenylalanine-restricted diet
●
some cases are due to reduced affinity of enzyme for cofactor
THB, can be treated with high dosages of THB
The Guthrie test for diagnosing phenylketonuria
© Michael Palmer 2014
Ochratoxin A inhibits phenylalanyl-tRNA
synthetase
© Michael Palmer 2014
Tyrosinemia
●
homozygous defect of fumarylacetoacetate hydrolase
●
fumarylacetoacetate and preceding metabolites back up
●
fumaryl- and maleylacetoacetate react with glutathione and
other nucleophiles, causing liver toxicity
●
the drug NTCB inhibits p-hydroxyphenylpyruvate
dioxygenase, intercepting the degradative pathway upstream
of the toxic metabolites
●
dietary restriction of tyrosine required to prevent neurological
deficit